Abstract
Seventeen patients (mean age 55 years) with suspected recurrence in previously operated and histologically confirmed colorectal adenocarcinomas were explored by immunoscintography (IS) associating planar and emission computed tomography (ECT) and using the 111In-labeled anti carcinoembryonic antigen (CEA) and(or) 19-9 monoclonal antibodies (MoAbs). The results of IS were compared blind with those of computed tomography (CT) and ultrasonography (US). The final diagnosis of recurrence and(or) metastasis was done in 16 cases by second-look surgery and in another patient by rectal biopsy. Overall per-patient sensitivity for the pelvis and extrahepatic abdomen was 69% for IS and 31% and 25% respectively for computed tomography and ultrasonography. No false positive of IS, as well as US and CT, for the pelvis and the extrahepatic abdomen was seen. Based on the number of anatomical sites tested, sensitivity of IS was 91% in the pelvis. In our series, scintigraphic computer subtraction did not allow adequate resolution of the problem of intense liver uptake of 111In-labeled MoAbs. It is concluded that IS using 111In-labeled anti CEA and(or) 19-9 MoAbs should be carried out prospectively in patients at high risk of recurrence of colorectal cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdel-Nabi HH, Schwartz AN, Goldfogel G (1988) Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings. Radiology 166:747–752
Andrew SM, Perkins AC, Pimm MV (1988) A comparison of iodine and indium labelled anti CEA intact antibody, F(ab)2 and Fab fragments by imaging tumour xenografts. Eur J Nucl Med 13:598–604
Beatty JD, Duda RB, Williams LE (1986) Preoperative imaging of colorectal carcinoma with 111In-labeled anticarcinoem-bryonicantigen monoclonal antibody. Cancer Res 46:6494–6502
Begent RH (1985) Recent advances in tumour imaging. Use of radiolabelled antitumour antibodies. Biochim Biophys Acta 780:151–166
Chatal JF, Saccavini JC, Fumoleau P (1984) Immunoscintigraphy of colon carcinoma. J Nucl Med 25:307–314
Delaloye B, Bischof-Delaloye A Buchegger F (1986) Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab)2 fragments from monoclonal anticarcinoembryonic antigen. J Clin Invest 77:301–311
Fairweather DS, Bradwell AR, Dykes PW (1983) Improved tumour localization using indium-111-labelled antibodies. Br Med J 287:167–170
Freeny PC, Marks WM, Ryan JA, Bolen JW (1986) Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence. Radiology 158:347–353
Goldenberg DM, Deland F, Kim E (1978) Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 298:1383–1388
Goodwin DA, Meares CF, McCall MS (1988) Pre-targeted immunoscintigraphy of murine tumors with Indium-111-labeled bifunctional haptens. J Nucl Med 29:226–234
Halpern SE, Haindl W, Beauregard J (1988) Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection. Radiology 168:529–536
Haseman MK, Goodwin DA, Meares CF (1986) Metabolizable 111-In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice. Eur J Nucl Med 12:455–460
Koprowski H, Steplewski Z, Mitchell K (1979) Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 5:957–971
Kramer EL, Sanger JJ, Walsh C (1988) contribution of SPECT to imaging of gastrointestinal adenocarcinoma with In-111-labeled anti-CEA monoclonal antibody. AJR 151:697–703
Krejcarek GE, Tucker KL (1977) Covalent attachment of chelating groups to macromolecules. Biochem Biophys Res Commun 77:581–585
Liehn JC, Hannequin P, Nasca S, Lebrun D, Cattan A, Valeyre J (1987) A new approach to image subtraction in immunoscintigraphy: preliminary results. Eur J Nucl Med 13:391–396
Mach JP, Buchegger F, Forni M (1981) Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinoma by external photoscanning and tomoscintigraphy. Immunol Today 2:239–249
Oberhausen E, Klein A, Berberich R (1987) Clinical trial of MAb 431/26 and MAb 431/31 labeled with different radionuclides. Nucl Med 26:51
Patt YZ, Lamki LM, Haynie TP (1988) Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer. J Clin Oncology 6:1220–1230
Philben VJ, Jakowitz JG, Beatty BG (1986) The effect of tumorcarcinoembryonic antigen (CEA) content and tumor size on tissue uptake of 111 indium-labeled anti-CEA monoclonal antibody. Cancer 57:571–576
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chetanneau, A., Lehur, P.A., Ripoche, D. et al. Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies. Eur J Nucl Med 15, 302–306 (1989). https://doi.org/10.1007/BF00435470
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00435470